150 related articles for article (PubMed ID: 22691695)
1. Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.
Palmer JM; Lee SJ; Chai X; Storer BE; Flowers ME; Schultz KR; Inamoto Y; Cutler C; Pidala J; Arora M; Jacobsohn DA; Carpenter PA; Pavletic SZ; Martin PJ
Biol Blood Marrow Transplant; 2012 Nov; 18(11):1649-55. PubMed ID: 22691695
[TBL] [Abstract][Full Text] [Related]
2. Validation of measurement scales in ocular graft-versus-host disease.
Inamoto Y; Chai X; Kurland BF; Cutler C; Flowers ME; Palmer JM; Carpenter PA; Heffernan MJ; Jacobsohn D; Jagasia MH; Pidala J; Khera N; Vogelsang GB; Weisdorf D; Martin PJ; Pavletic SZ; Lee SJ;
Ophthalmology; 2012 Mar; 119(3):487-93. PubMed ID: 22153706
[TBL] [Abstract][Full Text] [Related]
3. Clinical benefit of response in chronic graft-versus-host disease.
Inamoto Y; Martin PJ; Chai X; Jagasia M; Palmer J; Pidala J; Cutler C; Pavletic SZ; Arora M; Jacobsohn D; Carpenter PA; Flowers ME; Khera N; Vogelsang GB; Weisdorf D; Storer BE; Lee SJ;
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1517-24. PubMed ID: 22683612
[TBL] [Abstract][Full Text] [Related]
4. Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium.
Pidala J; Chai X; Martin P; Inamoto Y; Cutler C; Palmer J; Weisdorf D; Pavletic S; Arora M; Jagasia M; Jacobsohn D; Lee SJ
Biol Blood Marrow Transplant; 2013 Jun; 19(6):967-72. PubMed ID: 23542686
[TBL] [Abstract][Full Text] [Related]
5. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.
Lee SJ; Wolff D; Kitko C; Koreth J; Inamoto Y; Jagasia M; Pidala J; Olivieri A; Martin PJ; Przepiorka D; Pusic I; Dignan F; Mitchell SA; Lawitschka A; Jacobsohn D; Hall AM; Flowers ME; Schultz KR; Vogelsang G; Pavletic S
Biol Blood Marrow Transplant; 2015 Jun; 21(6):984-99. PubMed ID: 25796139
[TBL] [Abstract][Full Text] [Related]
6. Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.
Curtis LM; Datiles MB; Steinberg SM; Mitchell SA; Bishop RJ; Cowen EW; Mays J; McCarty JM; Kuzmina Z; Pirsl F; Fowler DH; Gress RE; Pavletic SZ
Haematologica; 2015 Sep; 100(9):1228-36. PubMed ID: 26088932
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium.
Pidala J; Kurland BF; Chai X; Vogelsang G; Weisdorf DJ; Pavletic S; Cutler C; Majhail N; Lee SJ
Haematologica; 2011 Oct; 96(10):1528-35. PubMed ID: 21685473
[TBL] [Abstract][Full Text] [Related]
8. Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.
Martin PJ; Storer BE; Palmer J; Jagasia MH; Chen GL; Broady R; Arora M; Pidala JA; Hamilton BK; Lee SJ
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1869-1874. PubMed ID: 31085305
[TBL] [Abstract][Full Text] [Related]
9. Design and Patient Characteristics of the Chronic Graft-versus-Host Disease Response Measures Validation Study.
Chronic GVHD Consortium
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1727-1732. PubMed ID: 29476954
[TBL] [Abstract][Full Text] [Related]
10. Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease.
Palmer J; Chai X; Pidala J; Inamoto Y; Martin PJ; Storer B; Pusic I; Flowers ME; Arora M; Pavletic SZ; Lee SJ
Blood; 2016 Jan; 127(1):160-6. PubMed ID: 26527676
[TBL] [Abstract][Full Text] [Related]
11. An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.
Martin PJ; Storer BE; Inamoto Y; Flowers MED; Carpenter PA; Pidala J; Palmer J; Arora M; Jagasia M; Arai S; Cutler CS; Lee SJ
Blood; 2017 Jul; 130(3):360-367. PubMed ID: 28495794
[TBL] [Abstract][Full Text] [Related]
12. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
13. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.
Arai S; Jagasia M; Storer B; Chai X; Pidala J; Cutler C; Arora M; Weisdorf DJ; Flowers ME; Martin PJ; Palmer J; Jacobsohn D; Pavletic SZ; Vogelsang GB; Lee SJ
Blood; 2011 Oct; 118(15):4242-9. PubMed ID: 21791424
[TBL] [Abstract][Full Text] [Related]
14. Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.
Cardones AR; Sullivan KM; Green C; Chao NJ; Rowe-Nichols K; Bañez LL; Burton CS; Horwitz ME; Long GD; Rao CL; Sarantopoulos S; Sidhu-Malik N; Sung AD; Hall RP
JAMA Dermatol; 2019 Jul; 155(7):833-837. PubMed ID: 30994873
[TBL] [Abstract][Full Text] [Related]
15. Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium.
Treister N; Chai X; Kurland B; Pavletic S; Weisdorf D; Pidala J; Palmer J; Martin P; Inamoto Y; Arora M; Flowers M; Jacobsohn D; Jagasia M; Arai S; Lee SJ; Cutler C
Bone Marrow Transplant; 2013 Aug; 48(8):1123-8. PubMed ID: 23353804
[TBL] [Abstract][Full Text] [Related]
16. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.
Baird K; Steinberg SM; Grkovic L; Pulanic D; Cowen EW; Mitchell SA; Williams KM; Datiles MB; Bishop R; Bassim CW; Mays JW; Edwards D; Cole K; Avila DN; Taylor T; Urban A; Joe GO; Comis LE; Berger A; Stratton P; Zhang D; Shelhamer JH; Gea-Banacloche JC; Sportes C; Fowler DH; Gress RE; Pavletic SZ
Biol Blood Marrow Transplant; 2013 Apr; 19(4):632-9. PubMed ID: 23340040
[TBL] [Abstract][Full Text] [Related]
17. The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality.
Pidala J; Kim J; Anasetti C; Nishihori T; Betts B; Field T; Perkins J
Haematologica; 2011 Nov; 96(11):1678-84. PubMed ID: 21791465
[TBL] [Abstract][Full Text] [Related]
18. Oral manifestations compatible with chronic graft-versus-host disease in patients with Fanconi anemia.
Grein Cavalcanti L; Fuentes Araújo RL; Bonfim C; Torres-Pereira CC
Biol Blood Marrow Transplant; 2015 Feb; 21(2):275-80. PubMed ID: 25316110
[TBL] [Abstract][Full Text] [Related]
19. Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease.
Inamoto Y; Martin PJ; Storer BE; Palmer J; Weisdorf DJ; Pidala J; Flowers ME; Arora M; Jagasia M; Arai S; Chai X; Pavletic SZ; Vogelsang GB; Lee SJ;
Haematologica; 2014 Oct; 99(10):1618-23. PubMed ID: 24997150
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.
Palmer J; Williams K; Inamoto Y; Chai X; Martin PJ; Tomas LS; Cutler C; Weisdorf D; Kurland BF; Carpenter PA; Pidala J; Pavletic SZ; Wood W; Jacobsohn D; Arai S; Arora M; Jagasia M; Vogelsang GB; Lee SJ
Biol Blood Marrow Transplant; 2014 Mar; 20(3):337-44. PubMed ID: 24315845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]